C-C chemokine receptor 3 antagonism by the β-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap

Journal of Immunology

Volumn 164, Issue 3, 2000, Pages 1488-1497

  Nibbs, Robert J B ^a   Salcedo, Theodora W ^b   Campbell, John D M ^c   Yao, Xiao Tao ^b   Li, Yuling ^b   Nardelli, Bernardetta ^b   Olsen, Henrik S ^b   Morris, Tina S ^b   Proudfoot, Amanda E I ^d   Patel, Vikram P ^b   Graham, Gerard J ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CHEMOKINE RECEPTOR CCR3; MACROPHAGE INFLAMMATORY PROTEIN; METHIONINE;

ALLERGY; AMINO TERMINAL SEQUENCE; ARTICLE; CELL INFILTRATION; EOSINOPHIL; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL;

EID: 0034142255     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.3.1488     Document Type: Article

References (53)

1. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
2. Rollins, B. J. 1997. Chemokines. Blood 90:909.
3. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565.
4. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S.-I. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635.
5. Graham, G. J., E. G. Wright, R. Hewick, S. D. Wolpe, N. M. Wilkie, D. Donaldson, S. Lorimore, and I. B. Pragnell. 1990. Identification and characterisation of an inhibitor of haemopoietic stem cell proliferation. Nature 344:442.
6. Harrison, J. K., Y. Jiang, S. Chen, Y. Xia, D. Maciejewski, R. K. McNamara, W. J. Streit, M. N. Salafranca, S. Adhikari, D. A. Thompson, et al. 1998. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. USA 95:10896.
7. Tachibana, K., S. Hirota, H. Iizasa, H. Yoshida, K. Kawabata, Y. Kataoka, Y. Kitamura, K. Matsushima, N. Yoshida, S.-I. Nishikawa, et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591.
8. Zou, Y.-R., A. H. Kottmann, M. Kuroda, I. Taniuchi, and D. R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595.
9. Murphy, P. M. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:47.
10. Premack, B. A., and T. J. Schall. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1174.
11. 3CR1, which mediates both leukocyte migration and adhesion. Cell 91:521.
12. Yoshida, T., T. Imai, M. Kakizaki, M. Nishimura, S. Takagi, and O. Yoshie. 1998. Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273:16551.
13. Clapham, P. R. 1997. HIV and chemokines: ligands sharing cell-surface receptors. Trends Cell Biol. 7:264.
14. Cairns, J. S., and M. P. D'Souza. 1998. Chemokines and HIV-1 second receptors: the therapeutic connection. Nat. Med. 4:563.
15. Weller, P. F. 1991. The immunobiology of eosinophils. N. Engl. J. Med. 324: 1110.
16. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1995. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. Trends Pharmacol. Sci. 16:418.
17. Uguccioni, M., C. R. Mackay, B. Ochensberger, P. Loetscher, S. Rhis, G. J. LaRosa, P. Rao, P. D. Ponath, M. Baggiolini, and C. A. Dahinden. 1997. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 100:1137.
18. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
19. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.
20. Gerber, B. O., M. P. Zanni, M. Uguccioni, M. Loetscher, C. R. Mackay, W. J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836.
21. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
22. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183: 2437.
23. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:2349.
24. Garcia-Zapeda, E. A., C. Combadiere, M. E. Rothenberg, M. N. Sarafi, F. Lavigne, Q. Hamid, P. M. Murphy, and A. D. Luster. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613.
25. Uguccioni, M., P. Loetscher, U. Forssmann, B. Dewald, H. Li, S. Hensche Lima, Y. Li, B. Kreider, S. Garotta, M. Thelen, and M. Baggiolini. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379.
26. Forssmann, U., M. Uguccioni, P. Loetscher, C. A. Dahinden, H. Langen, M. Thelen, and M. Baggiolini. 1997. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin or human eosinophil and basophil leukocytes. J. Exp. Med. 185:2171.
27. Kitayama, J., C. R. Mackay, P. D. Ponath, and T. A. Springer. 1998. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J. Clin. Invest. 101:2017.
28. Rothenberg, M. E., J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder. 1997. Targeted disruption of the chemokine eotaxin partially reduces Ag-induced tissue eosinophilia. J. Exp. Med. 185:785.
29. Teixeira, M. M., T. N. C. Wells, N. W. Lukacs, A. E. I. Proudfoot, S. L. Kunkel, T. J. Williams, and P. G. Hellewell. 1997. Chemokine-induced eosinophil recruitment. Evidence of a role for endogeneous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1657.
30. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95:6273.
31. Gonzalo, J.-A., C. M. Lloyd, D. Wen, J. P. Albar, T. N. C. Wells, A. Proudfoot, C. Martinez-A., M. Dorf, T. Bjerke, A. J. Coyle, and J.-C. Gutierrez-Ramos. 1998. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:157.
32. Elsner, J., H. Petering, R. Hochstetter, D. Kimmig, T. N. Wells, A. Kapp, and A. E. I. Proudfoot. 1997. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur. J. Immunol. 27:28192.
33. Adema, G. J., F. Hangers, R. Verstraten, E. de Vries, O. Marland, S. Menon, J. Foster, Y. Xu, P. Nooyen, T. McClanahan, K. B. Bacon, and C. G. Figdor. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
34. Hieshima, K., T. Imai, M. Baba, K. Shoudai, K. Ishizuka, T. Nakagawa, J. Tsuruta, M. Takeya, Y. Sakaki, K. Takatsuki, et al. 1997. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1α/LD78α and chemotactic for T lymphocytes, but not for monocytes. J. Immunol. 159:1140.
35. Wells, T. N. C., and M. C. Peitsch. 1997. The chemokine information source: identification and characterization of novel chemokines using the WorldWideWeb and expressed sequence tag databases. J. Leukocyte Biol. 61:545.
36. Kodelja, V., C. Muller, O. Politz, N. Hakij, C. E. Orfanos, and S. Goerdt. 1998. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1α with a Th2-associated expression pattern. J. Immunol. 160:1411.
37. Proudfoot, A. E. I., C. A. Power, A. J. Hoogewerf, M. O. Montjovent, F. Borlat, R. E. Offord, and T. N. C. Wells. 1996 Extension of recombinant human RANTES by the rcientior of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271:2599.
38. Simmons, G., P. R. Clapham, L. Picard, R. E. Offord, M. M. Rosenkilde, T. W. Schwartz, R. Buser, T. N. C. Wells, and A. E. I. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276.
39. Mack, M., B. Luckow, P. J. Nelson, J. Cihak, G. Simmons, P. R. Clapham, N. Signoret, M. Marsh, M. Stangassinger, F. Borlat, et al. 1998. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novei inhibitory mechanism of HIV infectivity. J. Exp. Med. 187:1215.
40. Nibbs, R. J. B., S. M. Wylie, J. Yang, N. Landau, and G. J. Graham. 1997. Cloning and characterization of a novel promiscuous human β-chemokine receptor, D6. J. Biol. Chem. 272:32078.
41. Hansel, T. T., J. M. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood cosinophils. J. Immunol. Methods 145:105.
42. Yang, O. O., S. L. Swanberg, Z. Lu, M. Dziejman, J. McCoy, A. D. Luster, B. D. Walker and S. H. Herrmann. 1999. Enhanced inhibition of human immunodeficiency virus type 1 by Met-Stromal-derived factor 1β correlates with down-modulation of CXCR4. J. Virol. 73:4582.
43. Zimmermann, N., J. J. Conkright, and M. E. Rothenberg. 1999. CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J. Biol. Chem. 274:12611.
44. Proost, P., I. DeMeester, D. Schols, S. Struyf, A.-M. Lambier, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpe, and J. Van Damme. 1998 Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 271:7222.
45. Proost, P., S. Struyf, M. Couvreur, J.-P. Lenaerts, R. Conings, P. Menten, P. Verhaert, A. Wuyts, and J. Van Damme. 1998. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2 (6-76) as a natural chemokine inhibitor. J. Immunol. 160:4034.
46. 2-terminal residue converts monocyte chemotactic protein-1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. 183:681.
47. Gong, J. H., M. Uguccioni, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1996 RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. 271:10521.
48. Struyf, S., I. DeMeester, S. Scharpe, J.-P. Lenaerts, P. Menten, J. M. Wang, P. Proost, and J. Van Damme. 1998. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28:1262.
49. Weng, Y., S. J. Siciliano, K. E. Waldburger, A. Sirotina-Meisher, M. J. Staruch, B. L. Daugherty, S. L. Gould, M. S. Springer, and J. A. DeMartino. 1998. Binding and functional properties of recombinant and endogeneous CXCR3 chemokine receptors. J. Biol. Chem. 273:18288.
50. Soto, H., W. Wang, R. M. Streiter, N. G. Copeland, D. G. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnick. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205.
51. Jenh, C.-H., M. A. Cox, H. Kaminski, M. Zhang, H. Byrnes, J. Fine, D. Lundell, C.-C. Chou, S. K. Narula, and P. J. Zavodny. 1999. Species specificity of the CC chemokine 6Ckine signalling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. J. Immunol. 162:3765.
52. Zingoni, A., H. Soto, J. A. Hedrick, A. Stoppacciaro, C. T. Storlazzi, F. Sinigaglia, D. D'Ambrosio, A. O'Garra, D. Robinson, M. Rocchi, et al. 1998. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J. Immunol. 161:547.
53. Bernadini, G., J. Hedrick, S. Sozzani, W. Luni, G. Spinetti, M. Weiss, S. Menon, A. Zlotnick, A. Mantovani, A. Santoni, and M. Napolitano. 1998. Identification of the CC chemokines T ARC and macrophage inflammatory protein-1β as novel functional ligands for the CCR8 receptor. Eur. J. Immunol. 28:582.